ML228 is a potent small molecule activator of the Hypoxia Inducible Factor (HIF) pathway with an EC50 of 1 µM. It effectively induces HIF signaling and its downstream target VEGF in vitro, making it a valuable research tool for studying hypoxia response, angiogenesis, and related disease models.